Collectively, all the above results suggest that tumor-derived lanosterol serves as an immune suppressive metabolite that limits the cytotoxic function of CD8+ T cells by reducing HMGCR protein level and thereby impairing KRAS-ERK signaling. The gene discussed is KRAS; the disease is neoplasm.